NeuroMetrix. has filed a patent for an apparatus designed for transcutaneous electrical nerve stimulation in humans. The device includes a housing, stimulation means, electrode array, control and monitoring systems, user interface, display, and a strap for targeted pain treatment. GlobalData’s report on NeuroMetrix gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights NeuroMetrix Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on NeuroMetrix, Wearable defibrillators was a key innovation area identified from patents. NeuroMetrix's grant share as of January 2024 was 62%. Grant share is based on the ratio of number of grants to total number of patents.

Transcutaneous electrical nerve stimulation apparatus for pain treatment

Source: United States Patent and Trademark Office (USPTO). Credit: NeuroMetrix Inc

The patent application (Publication Number: US20230381505A1) describes an apparatus designed for providing transcutaneous electrical nerve stimulation (TENS) to a user. The apparatus includes an electrical stimulator that generates electrical pulses suitable for TENS treatment, an electrode array with multiple electrodes for applying the generated pulses to the user's skin, and at least one thermal sensor connected to the stimulator to measure the user's skin temperature. The operation of the stimulator can be adjusted based on the measured skin temperature, enhancing the effectiveness and safety of the TENS treatment.

Furthermore, the apparatus in claim 124 specifies that the electrical pulses are current regulated, ensuring consistent and controlled stimulation. Claims 126 and 127 elaborate on the adjustment capabilities of the stimulator, indicating that the operation can be modified by changing the stimulation intensity or the duration of a treatment session. These features allow for personalized and adaptable TENS therapy based on the individual user's needs and skin temperature, potentially improving the overall treatment outcomes and user experience.

To know more about GlobalData’s detailed insights on NeuroMetrix, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies